| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | 27 | ||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | 32 | ||
| 2018 | Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy | Su T.-H.; Liao C.-H.; CHEN-HUA LIU ; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Radiology | 7 | ||
| 2015 | Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Journal of Infectious Diseases | 6 | ||
| 2007 | Age is not a discriminating factor for outcomes of therapeutic upper gastrointestinal endoscopy | Lee T.-C.; Huang S.-P.; Yang J.-Y.; Chang C.-Y.; Liou J.-M.; CHEN-HUA LIU ; Huang M.-S.; Wang H.-P. | Hepato-Gastroenterology | 10 | ||
| 2020 | Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer | Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; CHEN-HUA LIU ; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. | International Journal of Cancer | 3 | ||
| 2019 | Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism | Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; CHEN-HUA LIU ; Liu C.-J.; Chen C.-L.; Kao J.-H. | Movement Disorders | 6 | ||
| 2012 | Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients | Tsai H.-B.; Chen P.-C.; CHEN-HUA LIU ; Hung P.-H.; Chen M.-T.; Chiang C.-K.; Kao J.-H.; Hung K.-Y. | Nephrology Dialysis Transplantation | 9 | ||
| 2011 | Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy | Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; CHEN-HUA LIU ; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S. | Proceedings of the National Academy of Sciences of the United States of America | 54 | ||
| 2013 | Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients | Hsu C.-S.; Hsu S.-J.; Chen H.-C.; CHEN-HUA LIU ; Jeng J.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Hepatology International | 5 | ||
| 2009 | Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; Liu C.-J.; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. | American Journal of Gastroenterology | 34 | ||
| 2010 | Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Journal of Gastroenterology and Hepatology (Australia) | 28 | ||
| 2007 | Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma | Lin C.-L.; CHEN-HUA LIU ; Chen W.; Huang W.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. | Journal of Gastroenterology and Hepatology (Australia) | 73 | ||
| 2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; CHEN-HUA LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H. | Liver Cancer | 7 | ||
| 2005 | Biliary hamartomas with delayed 99mTc-diisopropyl iminodiacetic acid clearance | CHEN-HUA LIU ; Yen R.-F.; Liu K.-L.; Jeng Y.-M.; Pan M.-H.; Yang P.-M. | Journal of Gastroenterology | 3 | ||
| 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; CHEN-HUA LIU ; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. | Alimentary Pharmacology and Therapeutics | 20 | ||
| 2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; CHEN-HUA LIU ; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J. | Liver International | 10 | ||
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; CHEN-HUA LIU ; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. | Scientific Reports | 13 | ||
| 2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; CHEN-HUA LIU ; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Journal of Gastroenterology | 11 | ||
| 2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; CHEN-HUA LIU ; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J. | Hepatology International | 10 |
